Companies / Financials
FIS
Fidelity National Information Services
Transaction & Payment Processing Services
Transaction & Payment Processing ServicesAnalysis in progress
In progress
We are decoding this company's strategy and relationships
New analyses are published every weekday. Founding members get them first.
Business at a glance
Operating-health scores describe reported fundamentals on a 0–100 scale. They are not a rating of the stock. How they work
Operating health61
Growth40
Profitability44
Cash generationn/a
Balance sheetn/a
Dilution control98
Key ratios and five-year financials
Latest quarter revenue YoY (2026-09-30)27.1%Revenue growth (FY)5.4%Revenue CAGR (3y)3.2%Gross margin36.9%Operating margin16.3%Net margin3.6%Free cash flow margin23.0%R&D / revenue—Stock comp / revenue1.7%Net debt / operating cash flow5.28xCurrent ratio0.59Diluted share count change-5.4%
| Fiscal year ending | FY 2021-12 | FY 2022-12 | FY 2023-12 | FY 2024-12 | FY 2025-12 |
|---|---|---|---|---|---|
| Revenue | $9.3B | $9.7B | $9.8B | $10.1B | $10.7B |
| Gross profit | $3.3B | $3.5B | $3.7B | $3.8B | $3.9B |
| Operating income | $1.0B | $1.2B | $1.4B | $1.7B | $1.7B |
| Net income | $417M | -$16.8B | -$6.7B | $1.4B | $382M |
| Operating cash flow | $4.8B | $3.9B | $4.3B | $2.2B | $2.6B |
| Capital expenditure | $320M | $227M | $115M | $97M | $154M |
| Free cash flow | $4.5B | $3.7B | $4.2B | $2.1B | $2.5B |
| Stock-based comp | $383M | $189M | $120M | $186M | $181M |
| Buybacks | $2.1B | $1.9B | $522M | $4.0B | $1.4B |
| Dividends | $961M | $1.1B | $1.2B | $800M | $847M |
| Cash | $2.0B | $456M | $440M | $834M | $599M |
| Total debt | $22.0B | $22.2B | $20.4B | $12.3B | $14.4B |
| Equity | $47.3B | $27.2B | $19.1B | $15.7B | $13.9B |
StratGraph publishes general, impersonal research about public companies based on public filings. It is not investment advice, not a recommendation to buy, sell or hold any security, and not tailored to any reader's circumstances. Content may contain errors and may be partly generated with AI tools; verify against the original filings, which are linked. Authors may not trade securities discussed within the window set by our trading policy. Full disclaimer.